Developer docs
API playgroundTry for free, no card

Search company profiles

Sandu Pharmaceuticals

Full company profile

uuid003jdds

Namestring
Sandu Pharmaceuticals
Legal namestring
Sandu Pharmaceuticals Limited
Websiteurl
sandu.in
Company typeenum
Private
Founded yearint
1899
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ayurvedic medicines, herbal healthcare, wellness tonics, ayurvedic manufacturing, traditional medicine
Industry6 codes
1OTC Medicines & Consumer Health Products Distribution
CodeCRAOAHABPrimaryYes
2Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC)
CodeCRADAMAEPrimaryNo
3Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
CodeCRADAMADPrimaryNo
4OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
CodeCRADAMACPrimaryNo
5Allergy, Sinus & Respiratory (Non-Asthma)
CodeHLAIADACPrimaryNo
6Cold, Flu & Cough Remedies
CodeHLAIADABPrimaryNo
NAICS code3 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Health and Personal Care Retailers4561
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Ayurvedic Pharmaceuticals & Herbal Wellness
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Product Sales (Direct-to-Consumer)
TypeOne Time License
Description

Sandu Pharmaceuticals generates revenue through direct-to-consumer sales of its Ayurvedic medicines and wellness products via its e-commerce website sandu.in and physical retail/distribution. The company reported annual standalone sales of Rs 69.93 crore for the year ended March 2026, with quarterly standalone net sales of Rs 16.85 crore for Q4 March 2026.

business-standard.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Individual Ayurvedic products and combo bundles at various price points
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products range from approximately Rs 75 to Rs 3,290 per unit. Example prices: Sandu Gulkand Rs 230-Rs 775, Sandu Bilagyl Rs 234, Sandu Stresan Rs 107-Rs 1,284, Sandu Vasa Cough Syrup Rs 103-Rs 182, Sandu Bhringajeevani Rs 215, bundle kits from Rs 1,199 to Rs 1,911. Discounted items show savings of 3-27%.

sandu.in
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Sandu Research Foundation
Description

Full-fledged research unit of Sandu Pharmaceuticals group, involved in research and development activities.

sandu.in
Core offering1 text field

Sandu Pharmaceuticals manufactures and distributes over 100 Ayurvedic medicines and wellness products across therapeutic categories including digestive health, respiratory health, women's wellness, hair & skin care, heart health, liver health, and seasonal wellness (Rutucharya). The company sells its products directly to consumers through its own e-commerce website sandu.in and through physical retail distribution, combining traditional Ayurvedic formulations with modern pharmaceutical-grade aseptic manufacturing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Annual sales of Rs 69.93 crore for FY March 2026, growing 4.08% YoY
+2 more records
Product overview1 text field

Sandu Pharmaceuticals is an Ayurvedic medicine manufacturer established in 1899, operating as a direct-to-consumer e-commerce platform alongside traditional distribution channels. The company produces over 100 Ayurvedic products across multiple therapeutic categories including Digestive Health (Bilagyl, digestive Asavas/Arishtas, Churnas), Wellness (Makarprash, Hemocleen, Stresan for stress), Respiratory Health (Vasa Cough Syrup, respiratory formulas), Muscle & Bone Health (Maharasnadi Kadha, Osteon D, Balm), Hair & Skin Health (Bhringajeevani, Keshita Hair Oil, Sarivadyasav), Heart Health (Arjunarishta), Liver Health (Jaundex), and Female/Mother & Child Wellness (Ashoka Compound, Arvindasav, Shatari). The portfolio includes classical preparations like Asavas/Arishtas (fermented decoctions), Kadhas (herbal decoctions), Churnas (powders), Gutikas (tablets), and topical oils. Products are organized by seasonal wellness (Rutucharya) and health concerns, with Bundle Kits offering curated combinations. Manufacturing is ISO 9001:2000 certified across facilities in New Mumbai and Goa, supported by Sandu Research Foundation for product development.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

India's largest Ayurvedic FMCG company with a broad portfolio spanning digestive health (Hajmola), wellness (Chyawanprash), hair care, and OTC remedies. Comparable to Sandu across multiple Ayurvedic categories but operates at vastly greater scale across modern trade and global markets.

TypeDirect peer
Description

Ayurvedic personal care and wellness brand with products spanning skin care, oral care, and pain relief (Vicco Turmeric, Vicco VapoRub). Comparable mid-scale Indian Ayurvedic manufacturer with traditional positioning.

TypeBroad incumbent
Description

Fast-growing Ayurvedic and natural products company with broad portfolio covering digestive care, wellness, personal care, and groceries. Competes directly with Sandu's Ayurvedic positioning but at significantly larger scale and with stronger modern-retail penetration.

TypeDirect peer
Description

Indian OTC healthcare company with Ayurvedic pain relief balms, cough remedies, and women's wellness products. Direct overlap with Sandu's Vasa Cough Syrup and Sandu Balm product categories.

TypeOthers
Description

Listed Indian consumer goods company with adjacent Ayurvedic/natural hair and wellness brands. Less direct overlap than Dabur/Emami but competes for the same wellness-conscious consumer and retail shelf space.

TypeDirect peer
Description

Specialty Ayurvedic pharmaceutical company with focus on clinically-backed herbal formulations for women's health, pediatric care, and wellness. Comparable product mix and practitioner-channel positioning to Sandu.

TypeDirect peer
Description

Direct competitor in herbal/Ayurvedic OTC wellness products including digestive health, liver care (Liv.52), cough and cold, and personal care. Similar product breadth across herbal medicine categories and global distribution presence.

TypeDirect peer
Description

Ayurvedic OTC brand under Emami group with overlapping products in digestive health (Zandu Pancharishta), stress management, and wellness tonics. Also Mumbai-based with long Ayurvedic heritage, making it a geographically and product-overlapping competitor.

TypeDirect peer
Description

One of India's oldest Ayurvedic manufacturers (founded 1917), offering classical Ayurvedic formulations across digestive health, respiratory, liver, joint care, and wellness. Closely comparable heritage positioning and product portfolio to Sandu.

TypeEmerging player
Description

Ayurvedic and wellness brand combining classical formulations with modern retail and global expansion. Overlaps with Sandu's wellness product categories but has stronger brand marketing and urban premium positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sandu Pharmaceuticals

Ayurvedic Pharmaceuticals & Herbal Wellnesssandu.in

Sandu Pharmaceuticals firmographics

Firmographics
Name
Sandu Pharmaceuticals
Legal name
Sandu Pharmaceuticals Limited
Website
https://sandu.in
Company type
Private
Founded year
1899
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Sandu Pharmaceuticals industry classification

Industry
Product category
Ayurvedic Pharmaceuticals & Herbal Wellness
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Health and Personal Care Retailers (4561), Food (Health) Supplement Retailers (456191)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro primary industry
OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
akta.pro secondary industries
Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC), Cold, Flu & Cough Remedies (HLAIADAB)

Keywords

  • Ayurvedic medicines
  • Herbal healthcare
  • Wellness tonics
  • Ayurvedic manufacturing
  • Traditional medicine

Where Sandu Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Sandu Pharmaceuticals business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Product Sales (Direct-to-Consumer): Sandu Pharmaceuticals generates revenue through direct-to-consumer sales of its Ayurvedic medicines and wellness products via its e-commerce website sandu.in and physical retail/distribution. The company reported annual standalone sales of Rs 69.93 crore for the year ended March 2026, with quarterly standalone net sales of Rs 16.85 crore for Q4 March 2026.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual Ayurvedic products and combo bundles at various price points

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Sandu Pharmaceuticals product offering

Product offering

Core offering

Sandu Pharmaceuticals manufactures and distributes over 100 Ayurvedic medicines and wellness products across therapeutic categories including digestive health, respiratory health, women's wellness, hair & skin care, heart health, liver health, and seasonal wellness (Rutucharya). The company sells its products directly to consumers through its own e-commerce website sandu.in and through physical retail distribution, combining traditional Ayurvedic formulations with modern pharmaceutical-grade aseptic manufacturing.

Product overview

Sandu Pharmaceuticals is an Ayurvedic medicine manufacturer established in 1899, operating as a direct-to-consumer e-commerce platform alongside traditional distribution channels. The company produces over 100 Ayurvedic products across multiple therapeutic categories including Digestive Health (Bilagyl, digestive Asavas/Arishtas, Churnas), Wellness (Makarprash, Hemocleen, Stresan for stress), Respiratory Health (Vasa Cough Syrup, respiratory formulas), Muscle & Bone Health (Maharasnadi Kadha, Osteon D, Balm), Hair & Skin Health (Bhringajeevani, Keshita Hair Oil, Sarivadyasav), Heart Health (Arjunarishta), Liver Health (Jaundex), and Female/Mother & Child Wellness (Ashoka Compound, Arvindasav, Shatari). The portfolio includes classical preparations like Asavas/Arishtas (fermented decoctions), Kadhas (herbal decoctions), Churnas (powders), Gutikas (tablets), and topical oils. Products are organized by seasonal wellness (Rutucharya) and health concerns, with Bundle Kits offering curated combinations. Manufacturing is ISO 9001:2000 certified across facilities in New Mumbai and Goa, supported by Sandu Research Foundation for product development.

Differentiator

Problem solved

Functional benefit

Brands

  • Sandu Research Foundation: Full-fledged research unit of Sandu Pharmaceuticals group, involved in research and development activities.

Quantifiable outcome

  • Annual sales of Rs 69.93 crore for FY March 2026, growing 4.08% YoY
  • +2 more outcomes

Companies that use Sandu Pharmaceuticals

Customer profile

Segments3 records

Ideal customer profiles3 records

Sandu Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Sandu Pharmaceuticals partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Sandu Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • Dabur India: India's largest Ayurvedic FMCG company with a broad portfolio spanning digestive health (Hajmola), wellness (Chyawanprash), hair care, and OTC remedies. Comparable to Sandu across multiple Ayurvedic categories but operates at vastly greater scale across modern trade and global markets.
  • Patanjali Ayurved: Fast-growing Ayurvedic and natural products company with broad portfolio covering digestive care, wellness, personal care, and groceries. Competes directly with Sandu's Ayurvedic positioning but at significantly larger scale and with stronger modern-retail penetration.

Direct peers

  • Vicco Laboratories: Ayurvedic personal care and wellness brand with products spanning skin care, oral care, and pain relief (Vicco Turmeric, Vicco VapoRub). Comparable mid-scale Indian Ayurvedic manufacturer with traditional positioning.
  • Amrutanjan Health Care: Indian OTC healthcare company with Ayurvedic pain relief balms, cough remedies, and women's wellness products. Direct overlap with Sandu's Vasa Cough Syrup and Sandu Balm product categories.
  • Charak Pharma: Specialty Ayurvedic pharmaceutical company with focus on clinically-backed herbal formulations for women's health, pediatric care, and wellness. Comparable product mix and practitioner-channel positioning to Sandu.
  • Himalaya Wellness Company: Direct competitor in herbal/Ayurvedic OTC wellness products including digestive health, liver care (Liv.52), cough and cold, and personal care. Similar product breadth across herbal medicine categories and global distribution presence.
  • Zandu Pharmaceuticals (Emami): Ayurvedic OTC brand under Emami group with overlapping products in digestive health (Zandu Pancharishta), stress management, and wellness tonics. Also Mumbai-based with long Ayurvedic heritage, making it a geographically and product-overlapping competitor.
  • Baidyanath (Shree Baidyanath Ayurved Bhawan): One of India's oldest Ayurvedic manufacturers (founded 1917), offering classical Ayurvedic formulations across digestive health, respiratory, liver, joint care, and wellness. Closely comparable heritage positioning and product portfolio to Sandu.

Others

  • Marico (Kaya): Listed Indian consumer goods company with adjacent Ayurvedic/natural hair and wellness brands. Less direct overlap than Dabur/Emami but competes for the same wellness-conscious consumer and retail shelf space.

Emerging players

  • Sri Sri Tattva: Ayurvedic and wellness brand combining classical formulations with modern retail and global expansion. Overlaps with Sandu's wellness product categories but has stronger brand marketing and urban premium positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Sandu Pharmaceuticals social profiles

Digital presence

Sandu Pharmaceuticals compliance and trust

Trust signal

Compliance1 record

Sandu Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sandu Pharmaceuticals leadership team

Management profile

Number of profiles

Sandu Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sandu Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sandu Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sandu Pharmaceuticals

What does Sandu Pharmaceuticals do?

Sandu Pharmaceuticals manufactures and distributes over 100 Ayurvedic medicines and wellness products across therapeutic categories including digestive health, respiratory health, women's wellness, hair & skin care, heart health, liver health, and seasonal wellness (Rutucharya). The company sells its products directly to consumers through its own e-commerce website sandu.in and through physical retail distribution, combining traditional Ayurvedic formulations with modern pharmaceutical-grade aseptic manufacturing.

Is Sandu Pharmaceuticals a public or private company?

Sandu Pharmaceuticals is a private company. It is classified as public and is currently operating.

When was Sandu Pharmaceuticals founded?

Sandu Pharmaceuticals was founded in 1899. It employs 251 to 500 people.

Where is Sandu Pharmaceuticals based?

Sandu Pharmaceuticals is headquartered in Mumbai, India, in the Asia region.

How does Sandu Pharmaceuticals make money?

One revenue line is on record: product Sales (Direct-to-Consumer).

Who are Sandu Pharmaceuticals's main competitors?

Broad incumbents on record are Dabur India and Patanjali Ayurved. Direct peers are Vicco Laboratories, Amrutanjan Health Care, Charak Pharma, Himalaya Wellness Company, Zandu Pharmaceuticals (Emami) and Baidyanath (Shree Baidyanath Ayurved Bhawan). Marico (Kaya) is listed as an others. Sri Sri Tattva is listed as an emerging player.

Does Sandu Pharmaceuticals have an API?

No public API is recorded for Sandu Pharmaceuticals.

What industry is Sandu Pharmaceuticals in?

Sandu Pharmaceuticals's product category is Ayurvedic Pharmaceuticals & Herbal Wellness. Its primary akta.pro industry code is CRAOAHAB, OTC Medicines & Consumer Health Products Distribution, with a secondary code of CRADAMAE, Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXSandu Pharmaceuticals director Dr Neeti Gupta changes name post marriageSandu Pharmaceuticals notified the BSE that its Non-Executive Independent Director Dr Neeti Madan Kapre's name has been changed to Dr Neeti Gupta due to marriage. The company confirmed no change in designation or DIN, and the filing was made under SEBI LODR regulations.ScanXSandu Pharmaceuticals schedules 41st AGM for September 11, 2026Sandu Pharmaceuticals has scheduled its 41st Annual General Meeting for September 11, 2026, to be held via video conference following the reporting of a 23.2% increase in FY26 net profit to ₹176.62 lakh. The board recommended a final dividend of ₹1 per share and proposed the appointment of M/s. Dave & Dave as statutory auditors for a five-year term. Shareholders with a record date of September 4, 2026, are eligible to vote on these matters through remote e-voting.ScanXSandu Pharmaceuticals FY26 net profit rises 23.2% to ₹176.62 lakhSandu Pharmaceuticals announced a 23.2% increase in FY26 net profit to ₹176.62 lakh, driven by a 4.1% rise in revenue to ₹6,993.45 lakh. The board also recommended a final dividend of ₹1 per share and appointed M/s. Dave & Dave as statutory auditors for a five-year term. The company aims to maintain margin expansion despite a revenue decline in the first quarter of FY27.ScanXSandu Pharmaceuticals to consider MD appointment on July 11Sandu Pharmaceuticals Limited will hold a board meeting on July 11, 2026 to appoint a new Managing Director following the demise of Shri Umesh B. Sandu, the company's former Managing Director and Promoter. The board will also consider reconstituting its committees and appointing an additional independent director. A trading window has been closed from July 1, 2026 until 48 hours after the announcement of financial results for the quarter ended June 30, 2026.Business News TodaySandu Pharma Standalone March 2026 Net Sales at Rs 16.85 crore, up 19.79% Y-o-Y- Moneycontrol.comSandu Pharma reported standalone net sales of Rs 16.85 crore for March 2026, representing a 19.79% year-over-year increase.Business StandardSandu Pharmaceuticals standalone net profit declines 87.88% in the March 2026 quarterSandu Pharmaceuticals reported a standalone net profit decline of 87.88% to Rs 0.04 crore for the quarter ended March 2026, compared to Rs 0.33 crore in the same quarter of the previous year, despite sales rising 19.76% to Rs 16.85 crore. For the full year ended March 2026, the company posted a 14.19% rise in net profit to Rs 1.77 crore and a 4.08% increase in annual sales to Rs 69.93 crore. The sharp quarterly profit decline contrasts with the full-year performance, indicating a significant deterioration in profitability during the final quarter.NDTV ProfitSandu Pharmaceuticals Ltd. Share Price, Stock PriceSandu Pharmaceuticals Ltd. stock price as of May 21, 2026, opened at ₹39.00 versus a previous close of ₹38.42, trading within a range of ₹37.00 to ₹40.00. The stock has declined 30.68% year-on-year, with a 52-week low of ₹30.00 and high of ₹58.80. Market capitalization data for the company is listed as zero.